Omrix Biopharmaceuticals, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$37.9M

122 transactions

Summary

Omrix Biopharmaceuticals, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $1.5MSales: $34.6M28 insiders

Date	Insider	Type	Value
2008-03-26	Romagnoli Philippe	Buy	$106K
2008-03-31	Mashiach Nissim(President and COO)	Buy	$29K
2016-06-27	COTTER DOUGLAS A	A	$0
2010-06-27	Horowitz Bernard	A	$0
2008-11-23	Taub Robert(Chief Executive Officer)	A	$0
2008-10-23	Alperovitz Asaf(Chief Financial Officer)	A	$0
2008-10-10	Mashiach Nissim(President and COO)	A	$0
2008-09-04	ELLBERGER LARRY	A	$0
2008-09-04	ELLBERGER LARRY	A	$0
2008-09-04	Horowitz Bernard	A	$0
2008-09-04	Horowitz Bernard	A	$0
2008-09-04	RAKIN KEVIN	A	$0
2008-09-04	RAKIN KEVIN	A	$0
2008-09-04	Romagnoli Philippe	A	$0
2008-09-04	Romagnoli Philippe	A	$0
2008-09-04	St Peter Steven	A	$0
2008-09-04	St Peter Steven	A	$0
2008-09-04	Taub Robert(Chief Executive Officer)	A	$0
2008-05-15	MCNAMARA PAMELA W	A	$0
2008-05-15	MCNAMARA PAMELA W	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Omrix Biopharmaceuticals, Inc. — Contributions, Lobbying & Contracts | Poliscope